202 related articles for article (PubMed ID: 24590269)
1. Correlation of TNFAIP8 overexpression with the proliferation, metastasis, and disease-free survival in endometrial cancer.
Liu T; Gao H; Yang M; Zhao T; Liu Y; Lou G
Tumour Biol; 2014 Jun; 35(6):5805-14. PubMed ID: 24590269
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
4. TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.
Sun Z; Liu X; Song JH; Cheng Y; Liu Y; Jia Y; Meltzer SJ; Wang Z
Tumour Biol; 2016 Aug; 37(8):10923-34. PubMed ID: 26886285
[TBL] [Abstract][Full Text] [Related]
5. TNFAIP8 overexpression is associated with lymph node metastasis and poor prognosis in intestinal-type gastric adenocarcinoma.
Yang M; Zhao Q; Wang X; Liu T; Yao G; Lou C; Zhang Y
Histopathology; 2014 Oct; 65(4):517-26. PubMed ID: 24621012
[TBL] [Abstract][Full Text] [Related]
6. TNFAIP8 overexpression: clinical relevance to esophageal squamous cell carcinoma.
Hadisaputri YE; Miyazaki T; Suzuki S; Yokobori T; Kobayashi T; Tanaka N; Inose T; Sohda M; Kuwano H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S589-96. PubMed ID: 21969086
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of HABP1 correlated with clinicopathological characteristics and unfavorable prognosis in endometrial cancer.
Zhao J; Liu T; Yu G; Wang J
Tumour Biol; 2015 Feb; 36(2):1299-306. PubMed ID: 25355598
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ANCCA/ATAD2 in endometrial carcinoma and its correlation with tumor progression and poor prognosis.
Shang P; Meng F; Liu Y; Chen X
Tumour Biol; 2015 Jun; 36(6):4479-85. PubMed ID: 25934333
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
12. Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Steiner E; Eicher O; Sagemüller J; Schmidt M; Pilch H; Tanner B; Hengstler JG; Hofmann M; Knapstein PG
Int J Gynecol Cancer; 2003; 13(2):197-203. PubMed ID: 12657124
[TBL] [Abstract][Full Text] [Related]
13. TNFAIP8 as a predictor of metastasis and a novel prognostic biomarker in patients with epithelial ovarian cancer.
Liu T; Gao H; Chen X; Lou G; Gu L; Yang M; Xia B; Yin H
Br J Cancer; 2013 Sep; 109(6):1685-92. PubMed ID: 23982604
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of matrix metalloproteinase-9 (MMP9) correlates with clinical course in Chinese patients with endometrial cancer.
Yu F; Jiang Q; Zhou Y; Yang Z; Yu X; Wang H; Liu Z; Wang L; Fang W; Guo S
Dis Markers; 2012; 32(5):321-7. PubMed ID: 22674412
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.
Wakayama A; Kudaka W; Matsumoto H; Aoyama H; Ooyama T; Taira Y; Arakaki Y; Shimoji Y; Nakasone T; Nishihira K; Kaneshima I; Tamaki T; Yoshimi N; Aoki Y
Int J Clin Oncol; 2018 Jun; 23(3):532-538. PubMed ID: 29275449
[TBL] [Abstract][Full Text] [Related]
16. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
17. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
18. Association of TNFAIP8 gene polymorphisms with endometrial cancer in northern Chinese women.
Liu T; Jiang L; Yu L; Ge T; Wang J; Gao H
Cancer Cell Int; 2019; 19():105. PubMed ID: 31043860
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Wnt7a is associated with tumor progression and unfavorable prognosis in endometrial cancer.
Liu Y; Meng F; Xu Y; Yang S; Xiao M; Chen X; Lou G
Int J Gynecol Cancer; 2013 Feb; 23(2):304-11. PubMed ID: 23321718
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and p53 expressions in endometrial cancer.
Jeon YT; Kang S; Kang DH; Yoo KY; Park IA; Bang YJ; Kim JW; Park NH; Kang SB; Lee HP; Song YS
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1538-42. PubMed ID: 15342458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
